Insmed: Insmed To Present at March 2025 Investor Conferences

In This Article: BRIDGEWATER, N.J. , Feb. 11, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com . Webcasts will be archived for a period of 30 days following the conclusion of the live events. About Insmed Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in the United States , Europe , and Japan to treat a chronic, debilitating lung disease. The Company's early-stage research programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Headquartered in Bridgewater, New Jersey , Insmed has offices and research locations throughout the United States , Europe , and Japan . Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more. Contact: Investors: Bryan Dunn Vice President, Investor Relations (646) 812-4030 bryan.dunn@insmed.com Michael V. Morabito , Ph.D. Director, Investor Relations (917) 936-8430 michael.morabito@insmed.com Gianna De Palma Manager, Investor Relations (973) 886-2236 gianna.depalma@insmed.com Media: Mandy Fahey Vice President, Corporate Communications (732) 718-3621 amanda.fahey@insmed.com Insmed-Logo-Purple (PRNewsfoto/Insmed Incorporated) Cision